The Times of India has today reported that the Supreme Court has remanded the Sutent patent matter to the Patent Office for a hearing, and also set aside the injunction on Cipla's Sunitinib. This means the revocation of the Sutent patent of Sugen Inc has been set aside. The effect of this on proceedings for alleged infringement remains to be seen.
No comments:
Post a Comment